BTL-699-2 and HPM-6000UF Devices for the Improvement of Depressive Symptoms and Urinary Incontinence in Postpartum and Early Post-Childbirth Women
Public ClinicalTrials.gov record NCT07413692. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Safety and Efficacy of the Combined BTL-699-2 and HPM-6000UF Devices for the Improvement of Depressive Symptoms and Urinary Incontinence Among Postpartum Women and Women up to Five Years After Childbirth
Study identification
- NCT ID
- NCT07413692
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Not applicable
- Lead sponsor
- BTL Industries Ltd.
- Industry
- Enrollment
- 60 participants
Conditions and interventions
Conditions
Interventions
- EXOMIND (BTL-699-2) ActiveTreatment Device
- EMSELLA (HPM-6000UF) ActiveTreatment Device
- EXOMIND (BTL-699-2) Sham Treatment Device
- EMSELLA (HPM-6000UF) Sham Treatment Device
Device
Eligibility (public fields only)
- Age range
- 22 Years to 60 Years
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 24, 2025
- Primary completion
- Dec 10, 2026
- Completion
- Dec 10, 2026
- Last update posted
- Feb 16, 2026
2025 – 2026
United States locations
- U.S. sites
- 3
- U.S. states
- 3
- U.S. cities
- 3
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Charak Center for Health & Wellness | Garfield Heights | Ohio | 44125 | Recruiting |
| Optimal Health Associates | Oklahoma City | Oklahoma | 73114 | Recruiting |
| Tricia Shimer, M.D., P.A. | Dallas | Texas | 75231 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07413692, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 16, 2026 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07413692 live on ClinicalTrials.gov.